SIGA Technologies Inc (SIGA) - Total Liabilities

Latest as of March 2026: $67.77 Trillion USD

Based on the latest financial reports, SIGA Technologies Inc (SIGA) has total liabilities worth $67.77 Trillion USD as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

SIGA Technologies Inc - Total Liabilities Trend (1996–2025)

This chart illustrates how SIGA Technologies Inc's total liabilities have evolved over time, based on quarterly financial data. See SIGA Technologies Inc current assets vs equity to evaluate short-term liquidity relative to the company's equity base.

SIGA Technologies Inc Competitors by Total Liabilities

The table below lists competitors of SIGA Technologies Inc ranked by their total liabilities.

Company Country Total Liabilities
Jiangxi Hengda Hi-Tech Co Ltd
SHE:002591
China CN¥218.72 Million
Jiangsu Safety Wire Rope
SHG:603028
China CN¥2.17 Billion
T&L Co. Ltd
KQ:340570
Korea ₩20.08 Billion
KS Terminals Inc
TW:3003
Taiwan NT$1.57 Billion
Portillo's Inc
NASDAQ:PTLO
USA $1.12 Billion
Zumiez Inc
NASDAQ:ZUMZ
USA $334.57 Million
NACCO Industries Inc
NYSE:NC
USA $248.54 Million
Anaergia Inc
TO:ANRG
Canada CA$195.05 Million

Liability Composition Analysis (1996–2025)

This chart breaks down SIGA Technologies Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see SIGA Technologies Inc (SIGA) total market value.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 3.25 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.45 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.31 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how SIGA Technologies Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for SIGA Technologies Inc (1996–2025)

The table below shows the annual total liabilities of SIGA Technologies Inc from 1996 to 2025.

Year Total Liabilities Change
2025-12-31 $20.65 Million -27.64%
2024-12-31 $28.53 Million -50.37%
2023-12-31 $57.49 Million +131.12%
2022-12-31 $24.88 Million -38.44%
2021-12-31 $40.41 Million +101.68%
2020-12-31 $20.04 Million -80.12%
2019-12-31 $100.78 Million +0.25%
2018-12-31 $100.53 Million -78.51%
2017-12-31 $467.81 Million +4.33%
2016-12-31 $448.40 Million -4.63%
2015-12-31 $470.16 Million +13.87%
2014-12-31 $412.89 Million +133.47%
2013-12-31 $176.85 Million +130.00%
2012-12-31 $76.89 Million +57.90%
2011-12-31 $48.69 Million +225.43%
2010-12-31 $14.96 Million -3.01%
2009-12-31 $15.43 Million +113.00%
2008-12-31 $7.24 Million +35.11%
2007-12-31 $5.36 Million -20.54%
2006-12-31 $6.75 Million +134.72%
2005-12-31 $2.87 Million +85.26%
2004-12-31 $1.55 Million +182.97%
2003-12-31 $548.23K -16.54%
2002-12-31 $656.91K -1.40%
2001-12-31 $666.20K -70.85%
2000-12-31 $2.29 Million +90.45%
1999-12-31 $1.20 Million -20.00%
1998-12-31 $1.50 Million +200.00%
1997-12-31 $500.00K +150.00%
1996-12-31 $200.00K --

About SIGA Technologies Inc

NASDAQ:SIGA USA Drug Manufacturers - Specialty & Generic
Market Cap
$311.28 Million
Market Cap Rank
#14749 Global
#3442 in USA
Share Price
$4.34
Change (1 day)
+0.46%
52-Week Range
$4.17 - $9.48
All Time High
$22.50
About

SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security market in the United States. The company's lead product is TPOXX, an antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. was incorporated in 1995 and is headquartered in New York, New York.